Skip to main content
. 2017 Nov 16;17:83. doi: 10.1186/s12896-017-0400-3

Fig. 2.

Fig. 2

Transfection in suspension versus transfection of adherent cells. Brightfield and YFP fluorescence of (a) Sf9 suspension cells transfected with EMBacY construct #1, d5 post transfection, DNA:PEI = 1:2; (b) Sf9 adherent cells transfected with with EMBacY construct #1, d4 post transfection; transfection was performed with Cellfectin